title: Perspective study on pamidronate in stage I multiple myeloma.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Caparrotti
authors.forename: Lucio
authors.initials: L
authors.lastname: Catalano
authors.forename: Costanzo
authors.initials: C
authors.lastname: Feo
authors.forename: Roberto
authors.initials: R
authors.lastname: Vallone
authors.forename: David
authors.initials: D
authors.lastname: Pagnini
authors.forename: Bruno
authors.initials: B
authors.lastname: Rotoli
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D009367:Neoplasm Staging; D000077268:Pamidronate; D016019:Survival Analysis
chemical_list: D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077268:Pamidronate